Approved indication
Confirm the indication, age range, labeling, and approval status applicable in your market.
For healthcare professionals
Use the current, locally approved information.
Relixin is a botulinum toxin type A product. Product selection, preparation, administration, and patient management require qualified clinical judgment.
Preparation and administration
Use only the current locally approved product information. Detailed technique and dosing are intentionally not reproduced in this public website.
Safety information
Review all warnings, contraindications, interactions, precautions, and adverse-event information before use.
Need current materials?